Table 1

Ongoing clinical manifestations, disease activity assessments and therapies at baseline in the whole cohort

Whole cohort
Renal manifestations (%)8
Articular manifestations (%)20.3
Mucocutaneous manifestations (%)13.4
Neuropsychiatric manifestations (%)0.8
Serositis/haematological manifestations (%)17
SLEDAI (median, IQR)2 (0–4)
 SLEDAI=0 (%)31.3
 SLEDAI>4 (%)24.3
Serological activity (%)31
Glucocorticoids (%)84
Immunosuppressants (%)43.4
Biologics (%)0.8
Antimalarials (%)71.7
  • SLEDAI, SLE Disease Activity Index.